Clarus Ventures and Novo A/S back Nuvelution

Clarus Ventures and Novo A/S have provided an undisclosed investment in Nuvelution Pharma Inc. In addition to the funding, Nuvelution has named Dr. Barry Gertz and Dr. James Cornwall as chief physician scientist and chief business officer, respectively. Based in South San Francisco, Nuvelution is a solutions provider for R&D companies in the pharmaceutical and biotech industries to improve their productivity.

North AmericaUSBriefs